Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTUD7B | Q6GQQ9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12121672 | 0.88 | OTUD7B (0.34) | OTUD7B | |
| SCHEMBL19329547 | 0.82 | HSD17B10 (0.44) | OTUD7B | |
| SCHEMBL16901550 | 0.79 | OTUD7B (0.30) | OTUD7B | |
| SCHEMBL12405036 | 0.77 | CYP11B2 (0.36) | — | |
| SCHEMBL15698055 | 0.77 | CYP11B2 (0.36) | — | |
| SCHEMBL15187449 | 0.75 | GAA (0.33) | — | |
| SCHEMBL15186145 | 0.75 | — | — | |
| SCHEMBL16750986 | 0.74 | GRIN1 (0.36) | OTUD7B | |
| SCHEMBL16751010 | 0.74 | GRIN1 (0.38) | OTUD7B | |
| SCHEMBL29889350 | 0.74 | GAA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629146-B2 | Method for stereoselective synthesis of bicyclic heterocyclic compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20130211081-A1 | METHOD FOR STEREOSELECTIVE SYNTHESIS OF BICYCLIC HETEROCYCLIC COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-08-15 | — | — | US | disclosed |
| WO-2011015526-A1 | METHOD FOR STEREOSELECTIVE SYNTHESIS OF BICYCLIC HETEROCYCLIC COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130211081-A1 | METHOD FOR STEREOSELECTIVE SYNTHESIS OF BICYCLIC HETEROCYCLIC COMPOUNDS | CYP3A5, CYP11B2, CYP11B1 | OTUD7B 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.